HR 1271
115th Congress
House
Health
Child health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Licensing and registrations
Prescription drugs
Retail and wholesale trades
DXM Abuse Prevention Act of 2017
Introduced: March 1, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2017
Referred to the Subcommittee on Health.
Mar 1, 2017
Referred to the House Committee on Energy and Commerce.
Mar 1, 2017
Introduced in House
Plain-English summary
DXM Abuse Prevention Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2